-
“50 Years of Hematopoietic Stem Cell Transplantation”
We were honored to hear from Professor Xiaojun Huang of Peking University People’s Hospital and the Peking University Institute of Hematology, who shared a comprehensive reflection on the global evolution of hematopoietic stem cell transplantation (HSCT). From Dr. Edward Donnall Thomas’ foundational work to the creation of the Beijing Protocol, Professor Huang spotlighted how China’s…
-
CSCO Guidelines Conference | Academician Jinming Yu: From the “Jinan Miracle” in Radiation Therapy to Advancing Immunotherapy and International Collaboration
The 2025 CSCO Guidelines Conference, co-hosted by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, was successfully held in Jinan, April 18–19, 2025. Leading experts from across the country gathered once again to exchange cutting-edge research, discuss clinical hot topics, and witness the release of updated CSCO guidelines.…
-
EAU 2025 | Professor Alicia K. Morgans: Challenges and Breakthroughs in Prostate Cancer Treatment
UroStream: What are the current challenges in clinical practice for metastatic prostate cancer, and what breakthroughs have been achieved recently? Dr. Alicia K. Morgans: I think some of the biggest…
-
IHCAMS 2025 | International Workshop on Cell Therapy for Blood Diseases: Applications Now Open for Belt and Road Traineeship in Tianjin
An international event focusing on cellular therapy for blood diseases is approaching! From August 17 to Sep 1, 2025, in Tuanbo Campus,Tianjin, China, the International Workshop on Cell Therapy of…
-
EAU 2025 | Professor Anders Kjellman: Biopsy Before Treatment Plays a Key Role in Managing Small Renal Masses (SRMs)
Current Clinical Landscape: Biopsy Remains Underused in Small Renal Masses Despite advancements in imaging and surgical techniques, biopsy remains underutilized in the diagnosis of small renal masses (SRMs, ≤4 cm).…
-
CUDA Yanqi Lake Meeting | Professor Liqun Zhou: Advancing the Diagnostic Frontier to Improve Survival in Chinese Prostate Cancer Patients
In recent years, the incidence of prostate cancer in China has continued to rise, creating an urgent need to improve diagnostic and treatment strategies tailored to this growing patient population. At the 5th Annual CUDA Yanqi Lake Meeting (2025), hosted by the Chinese Urological Doctor Association, UroStream invited Professor Liqun Zhou, Institute of Urology, Peking…
-
EAU 2025 | Professor Renée C.A. Leenen Presents 20-Year ERSPC Follow-Up, Offering New Perspectives on Prostate Cancer Screening
UroStream: You shared the long-term follow-up data of the prostate cancer screening study at the EAU conference. Could you please share the main findings? What implications does this study bring…
Connecting Medical Expertise through Media
